Using NHSBT Blood for Researching and Developing Drug Candidates

• Research type

  Research Tissue Bank

• IRAS ID

  358849

• Research summary

  UCB NHSBT Cell Bank

• REC name

  South Central - Oxford C Research Ethics Committee

• REC reference

  25/SC/0191

• Date of REC Opinion

  4 Jul 2025

• REC opinion

  Favourable Opinion

• Data collection arrangements

  When blood is donated to the National Health Service Blood and Transplant to provide samples for clinical use, a byproduct of the apheresis process are leucocyte cones. These are made available for purchase as non-clinical components and contain blood that is enriched with many different cell types found naturally in the blood. The cells are useful in many assays employed in biological research. The research at UCB is focused on developing new drugs to treat severe inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and asthma. The leucocyte cone derived cells are key components of assays used in the research effort to further understand these diseases and in the associated development of drugs that ultimately, are aimed at providing therapeutic treatments.
  

• Research programme

  The samples obtained from the NHSBT are you solely for research and development purposes at UCB in the UK.

• Storage license

  12504

• RTBTitle

  UCB NHSBT Cell Bank

• Establishment organisation

  UCB

• Establishment organisation address

  216 Bath Road

  Slough

  Berkshire

  SL1 3WE